Insufficient scRNA-seq data for expression of SLC25A2 at single-cell level.
Insufficient scRNA-seq data for expression of SLC25A2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 96% | 16.12 | 236 / 245 | 1% | 0.01 | 4 / 502 |
| thymus | 92% | 10.32 | 601 / 653 | 0% | 0.00 | 1 / 605 |
| lung | 90% | 7.68 | 518 / 578 | 1% | 0.03 | 16 / 1155 |
| uterus | 89% | 7.53 | 152 / 170 | 0% | 0.01 | 2 / 459 |
| ovary | 89% | 8.54 | 161 / 180 | 0% | 0 | 0 / 430 |
| spleen | 89% | 8.63 | 215 / 241 | 0% | 0 | 0 / 0 |
| breast | 86% | 10.32 | 397 / 459 | 1% | 0.03 | 12 / 1118 |
| intestine | 82% | 5.35 | 792 / 966 | 1% | 0.02 | 5 / 527 |
| skin | 82% | 8.14 | 1479 / 1809 | 0% | 0.01 | 2 / 472 |
| kidney | 79% | 6.02 | 70 / 89 | 1% | 0.01 | 7 / 901 |
| liver | 78% | 6.47 | 177 / 226 | 0% | 0 | 0 / 406 |
| bladder | 76% | 5.19 | 16 / 21 | 2% | 0.03 | 8 / 504 |
| adrenal gland | 78% | 6.28 | 200 / 258 | 0% | 0 | 0 / 230 |
| adipose | 76% | 4.55 | 910 / 1204 | 0% | 0 | 0 / 0 |
| esophagus | 73% | 5.45 | 1056 / 1445 | 2% | 0.03 | 4 / 183 |
| pancreas | 74% | 3.83 | 243 / 328 | 0% | 0 | 0 / 178 |
| brain | 71% | 3.76 | 1874 / 2642 | 0% | 0.01 | 1 / 705 |
| blood vessel | 71% | 4.41 | 944 / 1335 | 0% | 0 | 0 / 0 |
| stomach | 68% | 3.27 | 244 / 359 | 1% | 0.03 | 3 / 286 |
| peripheral blood | 61% | 3.72 | 570 / 929 | 0% | 0 | 0 / 0 |
| heart | 55% | 2.46 | 475 / 861 | 0% | 0 | 0 / 0 |
| muscle | 44% | 1.61 | 355 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006591 | Biological process | ornithine metabolic process |
| GO_1903826 | Biological process | L-arginine transmembrane transport |
| GO_0000050 | Biological process | urea cycle |
| GO_1990575 | Biological process | mitochondrial L-ornithine transmembrane transport |
| GO_1903401 | Biological process | L-lysine transmembrane transport |
| GO_1903352 | Biological process | L-ornithine transmembrane transport |
| GO_0005743 | Cellular component | mitochondrial inner membrane |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0061459 | Molecular function | L-arginine transmembrane transporter activity |
| GO_0015189 | Molecular function | L-lysine transmembrane transporter activity |
| GO_0000064 | Molecular function | L-ornithine transmembrane transporter activity |
| GO_0015297 | Molecular function | antiporter activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | SLC25A2 |
| Protein name | Mitochondrial ornithine transporter 2 (Solute carrier family 25 member 2) |
| Synonyms | ORC2 ORNT2 |
| Description | FUNCTION: Mitochondrial transporter of the positively charged amino acids ornithine, lysine and arginine, and the neutral amino acid citrulline . In addition, transports the basic amino acids histidine, homoarginine, and asymmetric dimethylarginine (aDMA), but not symmetric DMA, and the D-forms of lysine, arginine, ornithine and histidine . Functions by both counter-exchange and uniport mechanisms . . |
| Accessions | ENST00000239451.7 Q9BXI2 |